Delivery Order SPE2DR25D3301-SPE2DR26F21RR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,075.62 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Injectafer is an intravenous iron replacement therapy used in the treatment of iron...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $15,003.41 firm fixed-price delivery order on August 5, 2025, for the supply of Injectafer 750 mg/15 mL vials. The contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Injectafer 750 mg/15 ml vials with a ceiling value of $8,747.15. This is a firm fixed-price delivery order with an ultimate completion date of December 22, 2025, issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $11,318.85 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials on December 19, 2025, with an ultimate completion date of December 22, 2025. This firm fixed price delivery order, issued without a set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $52,980.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials, with an ultimate completion date of February 2, 2026. This non-set-aside contract was competitively awarded on January 30, 2026, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials, with a ceiling value of $13,146.03. This non-competitive, firm fixed-price delivery order was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025. The place of performance is AmerisourceBergen Drug Corp's corporate office in Conshohocken, Pennsylvania. This award is executed under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $7,304.98 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on November 14, 2025, with completion scheduled for November 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Injectafer 750 mg/15 ml vials with a ceiling value of $13,079.20. This competitively awarded, firm fixed-price contract is classified as a child order and represents a non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order has an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $19,856.34 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order valued at $9,850.87 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This competitively awarded, firm fixed price delivery order was executed on December 22, 2025, with an ultimate completion date of December 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation, indicating the award was made through open...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F21RRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $30,162.18 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on February 2, 2026, with an ultimate completion date of February 3, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Injectafer is an intravenous iron replacement therapy used to treat iron deficiency anemia, making it a critical pharmaceutical supply for military healthcare systems. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031. This IDC serves as a global pharmaceutical support vehicle enabling the delivery of a comprehensive range of medications, specialty drugs, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's position as a major pharmaceutical distributor and federal contractor demonstrates its capability to fulfill specialized medical procurement requirements for the Defense Health Agency, military treatment facilities, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.2k | 2/1/26 |